Serious adverse events at time point closest to 90 days · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes serious adverse events at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.95 [0.59, 1.54]
1907 participants
Very low
Quality of life at time point closest to 90 days · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
1029 participants
Very low
Activities of daily living · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
569 participants
Very low
Patient readmissions · participants with internal medicine diseases and conditions
It is very uncertain whether short‐stay unit hospitalisation changes hospital readmission at time point closest to 90 days compared with usual care (very low certainty).
1 finding from 1 review
RR 0.8 [0.54, 1.19]
1753 participants
Very low
Non‐serious adverse events at time point closest to 90 days · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
533 participants
Very low
Costs · participants with internal medicine diseases and conditions
1 finding from 1 review
no estimate extracted
1433 participants
Very low
30‐day mortality* · people admitted to intensive care units
It is very uncertain whether automated monitoring systems changes 30‐day mortality* compared with standard care (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Duration of ICU stay · people admitted to intensive care units
1 finding from 1 review
Anxiety · adult ICU patients and their carers
1 finding from 1 review
Depression (lower scores mean less depression) · adult ICU patients and their carers
1 finding from 1 review
Duration of delirium Days · people with delirium
1 finding from 1 review
Children's ability to communicate effectively in everyday life: taking turns in conversation, initiating conversation and responding to others' conversational gambits · children up to 5 years of age with a communication difficulty associated with any non‐progressive motor disorder acquired before 2 years…
1 finding from 1 review
Successful treatment of exacerbation: number of participants cured. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants cured.… compared with oral monotherapy (very low certainty).
1 finding from 1 review
Successful treatment of exacerbation: number of participants with P aeruginosa eradication. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants with P… compared with oral monotherapy (very low certainty).
1 finding from 1 review
Serious adverse events. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes serious adverse events. Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Relapse · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes treatment response: relapse (day 42). Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Microbiological response: eradicated. Outcome assessed on day 21 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes microbiological response: eradicated. Outcome assessed on day 21 compared with oral monotherapy (very low certainty).
1 finding from 1 review
Feeding with more than 50% breast milk (days) · preterm infants
1 finding from 1 review
Neonatal sepsis ≤ 3 days · preterm infants
1 finding from 1 review
Time to closure or coverage surgery · open fracture wounds
1 finding from 1 review